Guidelines on the Management of Stable Angina Pectoris ... - Cardio

62 ESC <strong>Guidelines</strong>627. DePuey EG, Rozanski A. Using gated technetium-99m-sestamibi SPECTto characterize fixed myocardial defects as infarct or artifact. J NuclMed 1995;36:952–955.628. Dodi C, Cortigiani L, Masini M, Olivotto I, Azzarelli A, Nannini E. Theincremental prognostic value of pharmacological stress echo over exerciseelectrocardiography in women with chest pain of unknown origin.Eur Heart J 2001;22:145–152.629. Cortigiani L, Dodi C, Paolini EA, Bernardi D, Bruno G, Nannini E.Prognostic value of pharmacological stress echocardiography inwomen with chest pain and unknown coronary artery disease. JAmColl Cardiol 1998;32:1975–1981.630. Melin JA, Wijns W, Vanbutsele RJ, Robert A, De Coster P, Brasseur LAet al. Alternative diagnostic strategies for coronary artery disease inwomen: demonstration of the usefulness and efficiency of probabilityanalysis. Circulation 1985;71:535–542.631. Clarke KW, Gray D, Keating NA, Hampton JR. Do women with acute myocardialinfarction receive the same treatment as men? BMJ1994;309:563–566.632. Vaccarino V, Krumholz HM, Berkman LF, Horwitz RI. Sex differences inmortality after myocardial infarction. Is there evidence for an increasedrisk for women? Circulation 1995;91:1861–1871.633. Vaccarino V, Krumholz HM, Yarzebski J, Gore JM, Goldberg RJ. Sexdifferences in 2-year mortality after hospital discharge for myocardialinfarction. Ann Intern Med 2001;134:173–181.634. Roeters van Lennep JE, Zwinderman AH, Roeters van Lennep HW,Westerveld HE, Plokker HW, Voors AA et al. Gender differences in diagnosisand treatment of coronary artery disease from 1981 to 1997. Noevidence for the Yentl syndrome. Eur Heart J 2000;21:911–918.635. Daly CA, Clemens F, Sendon JL, Tavazzi L, Boersma E, Danchin N, DelahayeF, Gitt A, Julian D, Mulcahy D, Ruzyllo W, Thygesen K, Verheugt F,Fox KM; Euro Heart Survey Investigators. Gender differences inthe management and clinical outcome of stable angina. Circulation2006;113:467–469.636. Sowers JR. Diabetes in the elderly and in women: cardiovascular risks.Cardiol Clin 2004;22:541–551, vi.637. McFarlane SI, Banerji M, Sowers JR. Insulin resistance and cardiovasculardisease. J Clin Endocrinol Metab 2001;86:713–718.638. Blendea MC, McFarlane SI, Isenovic ER, Gick G, Sowers JR. Heart diseasein diabetic patients. Curr Diab Rep 2003;3:223–229.639. Turner RC, Millns H, Neil HA, Stratton IM, Manley SE, Matthews DR et al.Risk factors for coronary artery disease in non-insulin dependent diabetesmellitus: United Kingdom Prospective Diabetes Study (UKPDS:23). BMJ 1998;316:823–828.640. Wei M, Gaskill SP, Haffner SM, Stern MP. Effects of diabetes and level ofglycemia on all-cause and cardiovascular mortality. The San AntonioHeart Study. Diabetes Care 1998;21:1167–1172.641. Young LH, Jose P, Chyun D. Diagnosis of CAD in patients with diabetes:who to evaluate. Curr Diab Rep 2003;3:19–27.642. Anand DV, Lim E, Lahiri A, Bax JJ. The role of non-invasive imaging inthe risk stratification of asymptomatic diabetic subjects. Eur Heart J.2005.643. Giri S, Shaw LJ, Murthy DR, Travin MI, Miller DD, Hachamovitch R et al.Impact of diabetes on the risk stratification using stress single-photonemission computed tomography myocardial perfusion imaging inpatients with symptoms suggestive of coronary artery disease.Circulation 2002;105:32–40.644. Fang ZY, Sharman J, Prins JB, Marwick TH. Determinants of exercisecapacity in patients with type 2 diabetes. Diabetes Care 2005;28:1643–1648.645. The AACE System of intensive diabetes self-management-2002 update.The American Association of Clinical Endocrinologists Medical<strong>Guidelines</strong> for the management of diabetes mellitus. Endocr PractSuppl 2002;8(Suppl.):40–82.646. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucosecontrol with sulphonylureas or insulin compared with conventionaltreatment and risk of complications in patients with type 2 diabetes(UKPDS 33). Lancet 1998;352:837–853.647. Hellman R, Regan J, Rosen H. Effect of intensive treatment of diabetesof the risk of death or renal failure in NIDDM and IDDM. Diabetes Care1997;20:258–264.648. The American Association of Clinical Endocrinologists Medical <strong>Guidelines</strong>for the Management of Diabetes Mellitus: the AACE system of intensivediabetes self-management–2000 update. Endocr Pract 2000;6:43–84.649. Standl E, Schnell O. A new look at the heart in diabetes mellitus: fromailing to failing. Diabetologia 2000;43:1455–1469.650. Way KJ, Katai N, King GL. Protein kinase C and the development ofdiabetic vascular complications. Diabet Med 2001;18:945–959.651. Lernfelt B, Landahl S, Svanborg A. Coronary heart disease at 70, 75 and79 years of age: a longitudinal study with special reference to sex differencesand mortality. Age Ageing 1990;19:297–303.652. Kurita A, Takase B, Uehata A, Maruyama T, Nishioka T, Sugahara H et al.Painless myocardial ischemia in elderly patients compared withmiddle-aged patients and its relation to treadmill testing and coronaryhemodynamics. Clin Cardiol 1991;14:886–890.653. Vasilomanolakis EC. Geriatric cardiology: when exercise stress testing isjustified. Geriatrics 1985;40:47–50–53–4, 57.654. Kasser IS, Bruce RA. Comparative effects of aging and coronary heart diseaseon submaximal and maximal exercise. Circulation 1969;39:759–774.655. Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M et al. Asimple risk score for prediction of contrast-induced nephropathy afterpercutaneous coronary intervention: development and initial validation.J Am Coll Cardiol 2004;44:1393–1399.656. Montamat SC, Cusack BJ, Vestal RE. Management of drug therapy in theelderly. N Engl J Med 1989;321:303–309.657. Gundersen T, Abrahamsen AM, Kjekshus J, Ronnevik PK. Timolol-relatedreduction in mortality and reinfarction in patients ages 65-75 yearssurviving acute myocardial infarction. Prepared for the NorwegianMulticentre Study Group. Circulation 1982;66:1179–1184.658. Metzger JP, Tabone X, Georges JL, Gueniche C, Detienne JP, Le Feuvre Cet al. Coronary angioplasty in patients 75 years and older; comparisonwith coronary bypass surgery. Eur Heart J 1994;15:213–217.659. Bonnier H, de Vries C, Michels R, el Gamal M. Initial and long-termresults of coronary angioplasty and coronary bypass surgery in patientsof 75 or older. Br Heart J 1993;70:122–125.660. Mannheimer C, Camici P, Chester MR, Collins A, DeJongste M, Eliasson Tet al. The problem of chronic refractory angina; report from the ESCJoint Study Group on the Treatment of Refractory Angina. Eur Heart J2002;23:355–370.661. Brorsson B, Bernstein SJ, Brook RH, Werko L. Quality of life of patientswith chronic stable angina before and 4 years after coronary revascularisationcompared with a normal population. Heart 2002;87:140–145.662. Bernstein SJ, Brorsson B, Aberg T, Emanuelsson H, Brook RH, Werko L.Appropriateness of referral of coronary angiography patients inSweden. SECOR/SBU Project Group. Heart 1999;81:470–477.663. Yang EH, Barsness GW, Gersh BJ, Chandrasekaran K, Lerman A. Currentand future treatment strategies for refractory angina. Mayo Clin Proc2004;79:1284–1292.664. Faircloth ME, Redwood SR, Marber MS. Strategies for refractory angina–electricnot eclectic? Int J Clin Pract 2004;58:650–652.665. Kim MC, Kini A, Sharma SK. Refractory angina pectoris: mechanism andtherapeutic options. J Am Coll Cardiol 2002;39:923–934.666. Arora RR, Chou TM, Jain D, Fleishman B, Crawford L, McKiernan T et al.The multicenter study of enhanced external counterpulsation(MUST-EECP): effect of EECP on exercise-induced myocardial ischemiaand anginal episodes. J Am Coll Cardiol 1999;33:1833–1840.667. Soran O, Kennard ED, Kelsey SF, Holubkov R, Strobeck J, Feldman AM.Enhanced external counterpulsation as treatment for chronic anginain patients with left ventricular dysfunction: a report from theInternational EECP Patient Registry (IEPR). Congest Heart Fail2002;8:297–302.668. Linnemeier G, Rutter MK, Barsness G, Kennard ED, Nesto RW. EnhancedExternal Counterpulsation for the relief of angina in patients with diabetes:safety, efficacy and 1-year clinical outcomes. Am Heart J2003;146:453–458.669. Allen KB, Dowling RD, Angell WW, Gangahar DM, Fudge TL, Richenbacher Wet al. Transmyocardial revascularization: 5-year follow-up of a prospective,randomized multicenter trial. Ann Thorac Surg 2004;77:1228–1234.670. Schneider J, Diegeler A, Krakor R, Walther T, Kluge R, Mohr FW.Transmyocardial laser revascularization with the holmium:YAG laser:loss of symptomatic improvement after 2 years. Eur J CardiothoracSurg 2001;19:164–169.671. Schofield PM, Sharples LD, Caine N, Burns S, Tait S, Wistow T et al.Transmyocardial laser revascularisation in patients with refractoryangina: a randomised controlled trial. Lancet 1999;353:519–524.672. Leon MB, Kornowski R, Downey WE, Weisz G, Baim D, Bonow R,Hendel RC, Cohen D, Gervino E, Laham R, Lembo NJ, Moses JW, KuntzRE. A blinded, randomized, placebo-controlled trial of percutaneouslaser myocaridla revascularisation to improve angina symptoms inpatients with severe coronary disease. J Am Coll Cardiol 2005;46:1812–1819.